← Back to Search

Non-Invasive Continuous Remote Patient Monitoring for Heart Failure

Phase 2 & 3
Waitlist Available
Led By Nirav S Shah, MD, MPH
Research Sponsored by NorthShore University HealthSystem
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days from patient discharge date
Awards & highlights

Study Summary

This trial proposes to use a wearable device to predict physiological changes and perform continuous remote patient monitoring for post-discharge care.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days from patient discharge date
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days from patient discharge date for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Attrition Rate
Enrollment Rate
Secondary outcome measures
30-day Readmission
Number of Participants With Diuretic Escalation

Trial Design

2Treatment groups
Experimental Treatment
Group I: Phase II: Calibration (210 days)Experimental Treatment2 Interventions
After learning from the soft launch and updating the protocol, the study will continue to enroll 15 HF patients for calibration purposes
Group II: Phase I: Soft Launch (120 days)Experimental Treatment2 Interventions
The study will conduct a soft launch on the first five HF patients enrolled to finetune process and protocol.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Non-Invasive Continuous Remote Patient Monitoring
2020
Completed Phase 3
~20

Find a Location

Who is running the clinical trial?

Northwestern UniversityOTHER
1,601 Previous Clinical Trials
915,644 Total Patients Enrolled
20 Trials studying Heart Failure
4,283 Patients Enrolled for Heart Failure
NorthShore University HealthSystemLead Sponsor
132 Previous Clinical Trials
737,598 Total Patients Enrolled
1 Trials studying Heart Failure
43 Patients Enrolled for Heart Failure
physIQ, Inc.Industry Sponsor
3 Previous Clinical Trials
1,530 Total Patients Enrolled
1 Trials studying Heart Failure
400 Patients Enrolled for Heart Failure
~5 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top